A trial comparing Metvix® photodynamic therapy followed by Mohs micrographic surgery against Mohs micrographic surgery alone for the treatment of basal cell carcinoma
Basal cell carcinoma is the most common form of skin cancer in the UK. A specialised operation called Mohs micrographic surgery is often used to remove it carefully, layer by layer, saving as much healthy skin as possible. This trial investigates whether adding a treatment called Metvix photodynamic therapy before surgery can improve results. Photodynamic therapy involves putting a special cream on the skin cancer and shining a red light on it to destroy cancer cells. Researchers are comparing two groups of adults with larger skin tumours: one group receives the light therapy first and then has Mohs surgery, while the other group receives Mohs surgery alone. The aim is to see if treating the tumour with light first makes the surgery more effective, reduces tumour size, or improves healing.
At a glance
What is this study about?
Basal cell carcinoma (BCC) is a very common type of skin cancer that grows slowly and rarely spreads to other parts of the body. Even so, it needs treatment to stop it from growing deeper into the skin and surrounding tissues. A common and highly effective treatment is Mohs micrographic surgery. During this procedure, a surgeon removes thin layers of skin and checks each one under a microscope right away, continuing until no cancer cells remain.
Photodynamic therapy (PDT) is another way to treat certain skin cancers without an operation. In this trial, doctors use a cream called Metvix. The cream is absorbed by the cancer cells, and a special light is then shone on the area to activate the cream and destroy those cells.
Doctors want to find out whether having photodynamic therapy before Mohs surgery works better than just having the surgery alone. It is thought that treating the cancer with light first might help shrink the tumour or clear surface cancer cells, which could potentially make the surgery simpler or leave a smaller wound.
By taking part, patients help doctors understand whether combining these two existing treatments gives better results for people with larger skin cancers, helping to guide standard NHS care in the future.
Key takeaways
- The trial compares standard Mohs surgery against light therapy (Metvix PDT) followed by Mohs surgery.
- It is designed for adults with basal cell carcinomas measuring at least 100 square millimetres.
- Both treatments are already established ways of treating skin cancer.
- The aim is to find out if combining treatments improves tumour clearance and cosmetic results.
- Taking part is completely voluntary and will not affect your ongoing NHS medical care.
Who may be eligible?
You may be able to join this study if you are 18 or older and have been diagnosed with a basal cell carcinoma that is at least 100 square millimetres in size (about the size of a small fingernail or larger). Your doctor must also agree that your skin cancer is suitable for Mohs surgery. Because of safety precautions around the medications, women who take part must not be able to have children (for example, those who have gone through the menopause or had sterilisation surgery).
You will not be able to join if your skin cancer is smaller than 100 square millimetres, or if it is a specific scarring type known as morphoeic basal cell carcinoma, which needs different care. Women who are able to become pregnant cannot take part in this trial.
You will also be excluded if you have rare medical conditions that make your skin unusually sensitive to light (such as porphyria or xeroderma pigmentosum), or if you are allergic to Metvix cream or any of its ingredients. Finally, you cannot join if you have taken part in another clinical trial within the past 30 days.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or over.
- I have been diagnosed with a basal cell carcinoma measuring at least 1 cm by 1 cm.
- My doctor has advised that Mohs surgery is a suitable treatment for me.
- I am either male, or a female who is no longer able to have children.
- I do not have a medical condition that makes my skin extremely sensitive to light.
- I have not taken part in another clinical trial in the last 30 days.
What does participation involve?
Taking part involves attending clinic visits for assessment and treatment. If you are placed in the combination group, you will first have photodynamic therapy, which involves having the Metvix cream applied to your skin, waiting a few hours for it to soak in, and then sitting under a special red light for several minutes. After this, you will have your Mohs surgery. If you are in the surgery-only group, you will go straight to having Mohs surgery under local anaesthetic. After your treatment, doctors will check your wound, monitor how your skin heals, and check for any signs of the cancer returning. The study team will give you a clear schedule showing how many visits you will need and over what time period.
Potential risks and benefits
Locations (1)
- Dermatological Surgery and Laser UnitCity onlyLondon, England
Common questions
What is Mohs micrographic surgery?
It is a precise type of skin surgery where the doctor removes skin layer by layer and examines each layer under a microscope until all cancer cells are gone, leaving behind as much healthy skin as possible.
Does photodynamic therapy hurt?
Many people feel a warm, stinging, or prickling sensation while the light is shining on the skin. The team can use cooling fans, water sprays, or local anaesthetic to keep you comfortable.
Can I choose which treatment group I am in?
No. In clinical trials like this, participants are usually put into groups by chance (randomly) so doctors can make a fair comparison between the two approaches.
Will having this treatment leave a scar?
Yes. Any surgical removal of skin leaves a scar. Mohs surgery is designed to keep scars as small as possible, and the study team will advise you on how to care for your wound.
What happens if I change my mind about taking part?
You are free to leave the study at any time. If you choose to stop, you will still receive the standard recommended treatment for your skin cancer.
How to find out more
Habib Kurwa
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.